Search research articles
Contact Us
Filters
Showing results (11-20 of 62) with videos related to
Page
of 7
Sort By:
Expert Review of Neurotherapeutics
|
December 9, 2014
Pharmacotherapy of Alzheimer's disease: current and future trends
Werner J Geldenhuys, Altaf S Darvesh
Brain Research
|
August 16, 2005
Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT
Altaf S Darvesh, Gary A Gudelsky
Current Alzheimer Research
|
November 27, 2009
Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues
S Darvesh, G A Reid, E Martin
Cancer Treatment Reviews
|
November 14, 2009
Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma
Anupam Bishayee, Themos Politis, Altaf S Darvesh
Neuroscience
|
January 12, 2013
Butyrylcholinesterase and the cholinergic system
G A Reid, N Chilukuri, S Darvesh
Current Pharmaceutical Biotechnology
|
April 7, 2011
Curcumin and liver cancer: a review
Altaf S Darvesh, Bharat B Aggarwal, Anupam Bishayee
Neuroepidemiology
|
August 26, 1999
Spectrum of disease in vascular cognitive impairment
K Rockwood, K Howard, C MacKnight, et al.
The Journal of Comparative Neurology
|
April 21, 1998
Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation
S Darvesh, D L Grantham, D A Hopkins
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2002
3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain
Altaf S Darvesh, Mahalakshmi Shankaran, Gary A Gudelsky
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 19, 2010
Resveratrol and liver disease: from bench to bedside and community
Anupam Bishayee, Altaf S Darvesh, Themos Politis, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 62) with videos related to
Sort By:
Page
of 7
Expert Review of Neurotherapeutics
|
December 9, 2014
Pharmacotherapy of Alzheimer's disease: current and future trends
Werner J Geldenhuys, Altaf S Darvesh
Brain Research
|
August 16, 2005
Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT
Altaf S Darvesh, Gary A Gudelsky
Current Alzheimer Research
|
November 27, 2009
Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues
S Darvesh, G A Reid, E Martin
Cancer Treatment Reviews
|
November 14, 2009
Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma
Anupam Bishayee, Themos Politis, Altaf S Darvesh
Neuroscience
|
January 12, 2013
Butyrylcholinesterase and the cholinergic system
G A Reid, N Chilukuri, S Darvesh
Current Pharmaceutical Biotechnology
|
April 7, 2011
Curcumin and liver cancer: a review
Altaf S Darvesh, Bharat B Aggarwal, Anupam Bishayee
Neuroepidemiology
|
August 26, 1999
Spectrum of disease in vascular cognitive impairment
K Rockwood, K Howard, C MacKnight, et al.
The Journal of Comparative Neurology
|
April 21, 1998
Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation
S Darvesh, D L Grantham, D A Hopkins
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2002
3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain
Altaf S Darvesh, Mahalakshmi Shankaran, Gary A Gudelsky
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 19, 2010
Resveratrol and liver disease: from bench to bedside and community
Anupam Bishayee, Altaf S Darvesh, Themos Politis, et al.
Page
of 7